Literature DB >> 12079535

The effects of low-dose X-irradiation on the oxidative burst in stimulated macrophages.

D Schaue1, B Marples, K R Trott.   

Abstract

PURPOSE: Local irradiation with a dose of around 0.5 Gy is an effective treatment of acute necrotizing inflammations. The hypothesis that low doses of X-rays modulate the oxidative burst in activated macrophages, which plays a major role in the acute inflammatory process, was tested.
MATERIALS AND METHODS: Murine RAW 264.7 macrophages were stimulated with LPS/gammaIFN, PMA or zymosan and oxidative burst was measured using either DCFH-DA or by reduction of cytochrome-C. Radiation doses of 0.3-10 Gy were given shortly before or after stimulation.
RESULTS: Low X-ray doses of <1 Gy significantly reduced the oxidative burst in activated macrophages, whereas higher doses had little effect on oxidative burst.
CONCLUSIONS: The modulation of oxidative burst by low radiation doses may contribute to the therapeutic effectiveness of low-dose radiotherapy of acute necrotizing inflammations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12079535     DOI: 10.1080/09553000210126457

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  29 in total

1.  The effect of vitamin A pretreatment on radiation induced alteration in neutrophil functions.

Authors:  Barbaros Balabanli; Nurten Türközkan; Sema Balabanli; Husamettin Erdamar; Müge Akmansu
Journal:  Mol Cell Biochem       Date:  2006-02-14       Impact factor: 3.396

Review 2.  Anti-inflammatory effects of low-dose radiotherapy. Indications, dose, and radiobiological mechanisms involved.

Authors:  M Arenas; S Sabater; V Hernández; A Rovirosa; P C Lara; A Biete; J Panés
Journal:  Strahlenther Onkol       Date:  2012-08-22       Impact factor: 3.621

3.  Flying by the seat of our pants: is low dose radiation therapy for COVID-19 an option?

Authors:  Dörthe Schaue; William H McBride
Journal:  Int J Radiat Biol       Date:  2020-05-26       Impact factor: 2.694

4.  DEGRO practical guidelines for radiotherapy of non-malignant disorders: Part I: physical principles, radiobiological mechanisms, and radiogenic risk.

Authors:  Berthold Reichl; Andreas Block; Ulrich Schäfer; Christoph Bert; Reinhold Müller; Horst Jung; Franz Rödel
Journal:  Strahlenther Onkol       Date:  2015-06-28       Impact factor: 3.621

5.  Benign painful elbow syndrome. First results of a single center prospective randomized radiotherapy dose optimization trial.

Authors:  O J Ott; S Hertel; U S Gaipl; B Frey; M Schmidt; R Fietkau
Journal:  Strahlenther Onkol       Date:  2012-08-25       Impact factor: 3.621

6.  Benign painful shoulder syndrome: initial results of a single-center prospective randomized radiotherapy dose-optimization trial.

Authors:  O J Ott; S Hertel; U S Gaipl; B Frey; M Schmidt; R Fietkau
Journal:  Strahlenther Onkol       Date:  2012-11-07       Impact factor: 3.621

7.  Immunomodulatory properties and molecular effects in inflammatory diseases of low-dose x-irradiation.

Authors:  Franz Rödel; Benjamin Frey; Katrin Manda; Guido Hildebrandt; Stephanie Hehlgans; Ludwig Keilholz; M Heinrich Seegenschmiedt; Udo S Gaipl; Claus Rödel
Journal:  Front Oncol       Date:  2012-09-25       Impact factor: 6.244

8.  Chronic Internal Exposure to Low Dose 137Cs Induces Positive Impact on the Stability of Atherosclerotic Plaques by Reducing Inflammation in ApoE-/- Mice.

Authors:  Clélia Le Gallic; Yohann Phalente; Line Manens; Isabelle Dublineau; Marc Benderitter; Yann Gueguen; Stephanie Lehoux; Teni G Ebrahimian
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

9.  Cancer-associated fibroblasts from lung tumors maintain their immunosuppressive abilities after high-dose irradiation.

Authors:  Laia Gorchs; Turid Hellevik; Jack-Ansgar Bruun; Ketil-Andre Camilio; Samer Al-Saad; Tor-Brynjar Stuge; Inigo Martinez-Zubiaurre
Journal:  Front Oncol       Date:  2015-05-12       Impact factor: 6.244

10.  How does ionizing irradiation contribute to the induction of anti-tumor immunity?

Authors:  Yvonne Rubner; Roland Wunderlich; Paul-Friedrich Rühle; Lorenz Kulzer; Nina Werthmöller; Benjamin Frey; Eva-Maria Weiss; Ludwig Keilholz; Rainer Fietkau; Udo S Gaipl
Journal:  Front Oncol       Date:  2012-07-25       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.